Kathy Hagy

Kathy Hagy is an accomplished Key Account Manager with extensive experience in biotech and specialty sales, currently serving at Melinta Therapeutics since November 2017 and recognized as a President’s Club CEO in 2019. Prior to this role, Kathy held significant positions at The Medicines Company, where marketing and promotion of new products were executed for health systems, and at Durata Therapeutics as a Market Development Manager, specializing in the launch and promotion of new biotech products. Additional experience includes sales roles at Optimer Pharmaceuticals, Genentech, and Roche, with a proven track record of successful product launches, formulary acceptances, and relationship development within hospital systems. Kathy earned a degree from East Tennessee State University.